Guardian Pharmacy Services (NYSE:GRDN) Lowered to Hold Rating by Wall Street Zen

Wall Street Zen lowered shares of Guardian Pharmacy Services (NYSE:GRDN - Free Report) from a buy rating to a hold rating in a report issued on Saturday morning.

Several other equities research analysts have also issued reports on the stock. Truist Financial reaffirmed a "buy" rating and issued a $28.00 price objective (up previously from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday, May 19th. Raymond James set a $28.00 price objective on shares of Guardian Pharmacy Services and gave the stock an "outperform" rating in a report on Wednesday, May 14th.

Guardian Pharmacy Services Price Performance

Shares of NYSE GRDN traded up $0.21 during mid-day trading on Friday, reaching $22.15. 1,121,038 shares of the company traded hands, compared to its average volume of 166,268. Guardian Pharmacy Services has a fifty-two week low of $14.16 and a fifty-two week high of $26.91. The stock has a fifty day simple moving average of $23.13 and a 200-day simple moving average of $22.00.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.01). The business had revenue of $329.31 million for the quarter, compared to analysts' expectations of $321.21 million. As a group, equities research analysts forecast that Guardian Pharmacy Services will post 0.87 EPS for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. acquired a new position in Guardian Pharmacy Services in the fourth quarter valued at about $544,000. Rhumbline Advisers bought a new stake in Guardian Pharmacy Services in the fourth quarter valued at approximately $149,000. New York State Common Retirement Fund increased its stake in Guardian Pharmacy Services by 17.9% in the fourth quarter. New York State Common Retirement Fund now owns 278,548 shares of the company's stock valued at $5,643,000 after purchasing an additional 42,368 shares in the last quarter. Wells Fargo & Company MN increased its stake in Guardian Pharmacy Services by 353.7% in the fourth quarter. Wells Fargo & Company MN now owns 6,715 shares of the company's stock valued at $136,000 after purchasing an additional 5,235 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its position in shares of Guardian Pharmacy Services by 364.6% during the fourth quarter. Russell Investments Group Ltd. now owns 73,241 shares of the company's stock worth $1,484,000 after acquiring an additional 57,475 shares in the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.